<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30086430</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>10</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1872-6968</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>173</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Clinical neurology and neurosurgery</Title>                <ISOAbbreviation>Clin Neurol Neurosurg</ISOAbbreviation>            </Journal>            <ArticleTitle>Diagnosis of brain metastases in breast cancer patients resulting from neurological symptoms.</ArticleTitle>            <Pagination>                <MedlinePgn>61-64</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0303-8467(18)30313-5</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clineuro.2018.08.002</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Breast cancer (BC) is the leading cause of morbidity and mortality. Neurological symptoms are highly feared because they are associated with central nervous system metastases (CNSm). So, we aimed to analyze the association of neurological symptoms with CNSm.</AbstractText>                <AbstractText Label="PATIENTS &amp; METHODS" NlmCategory="METHODS">Patients with BC referred for a neuro-oncological evaluation at a cancer referral center from June 2012 to December 2017 were included. Demographic, oncological history, comorbidities, clinical symptoms and signs, and their correlation with CNSm were prospectively acquired during consultation in a computerized database. Analyses included descriptive observations, bivariate, and logistic linear regression tests that compared associations.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 857 patients with BC were referred for assessment. The most frequently occurring symptoms included headache, focal motor weakness, focal-sensitive complaints, and visual complaints. Of the 1029 neuro-oncology diagnoses made, the most common were CNSm, primary headache, and chemotherapy-induced neuropathy. The risk factors associated with CNSm in patients with neurological symptoms were HER2+, younger age at cancer diagnosis, presence of extracranial metastases, and &gt;1 neurological symptom (mainly headache: hazard ratio (HR), 2.1 [95% confidence interval (CI), 1.5-2.7]; visual complaints: HR, 2.3 (95%CI, 1.2-4.2); and ataxia: HR, 2.1 (95%CI,1.04-4.3).</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical symptoms and cancer characteristics were correlated with the development of CNSm. Specific risk and protective factors were identified. Among BC patients with neurological symptoms, CNSm should always be considered, especially in patients with certain oncological and clinical features.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Cacho-Díaz</LastName>                    <ForeName>Bernardo</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Neuro-Oncology Unit, National Cancer Institute, Mexico. Electronic address: bernardocacho@doctor.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Spínola-Maroño</LastName>                    <ForeName>Héctor</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Neuro-Oncology Unit, National Cancer Institute, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Arrieta</LastName>                    <ForeName>Victor A</ForeName>                    <Initials>VA</Initials>                    <AffiliationInfo>                        <Affiliation>Neuro-Oncology Unit, National Cancer Institute, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Granados-García</LastName>                    <ForeName>Martin</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Head and Neck Department, National Cancer Institute, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wegman-Ostrosky</LastName>                    <ForeName>Talia</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Research Division, National Cancer Institute, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mendoza-Olivas</LastName>                    <ForeName>Laura G</ForeName>                    <Initials>LG</Initials>                    <AffiliationInfo>                        <Affiliation>Head and Neck Department, National Cancer Institute, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chávez-MacGregor</LastName>                    <ForeName>Mariana</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Health Services Research, Breast Medical Oncology Departments at the University of Texas MD Anderson Cancer Center, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>02</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Clin Neurol Neurosurg</MedlineTA>            <NlmUniqueID>7502039</NlmUniqueID>            <ISSNLinking>0303-8467</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Central nervous system metastases</Keyword>            <Keyword MajorTopicYN="N">Metastatic breast cancer</Keyword>            <Keyword MajorTopicYN="N">Neuro-oncology</Keyword>            <Keyword MajorTopicYN="N">Neurological symptoms</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30086430</ArticleId>            <ArticleId IdType="pii">S0303-8467(18)30313-5</ArticleId>            <ArticleId IdType="doi">10.1016/j.clineuro.2018.08.002</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>